IFP Advisors’s Matinas BioPharma MTNB Stock Holding History

IFP Advisors’s Portfolio MTNB Stock Details MTNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Hold	0	–	-$1	–	4527
2024 Q4	–	Hold	0	–	–	–	4588
2024 Q3	–	Sell	-1	Closed	-$102	–	3397
2024 Q2	$102	Hold	1	–	–	﹤0.01%	3168
2024 Q1	$174	Hold	1	–	–	﹤0.01%	3037
2023 Q4	$139	Hold	1	–	–	﹤0.01%	2957
2023 Q3	$83	Hold	1	–	–	﹤0.01%	3227
2023 Q2	$231	Hold	1	–	–	﹤0.01%	3304
2023 Q1	$383	Hold	1	–	–	﹤0.01%	3216
2022 Q4	$2K	Hold	1	–	–	﹤0.01%	4186
2022 Q3	$2K	Hold	1	–	–	﹤0.01%	4380
2022 Q2	$2K	Hold	1	–	–	﹤0.01%	4153
2022 Q1	$2K	Hold	1	–	–	﹤0.01%	4150
2021 Q4	$2K	Hold	1	–	–	﹤0.01%	2817
2021 Q3	$2K	Hold	1	–	–	﹤0.01%	2880
2021 Q2	$0	Sell	1 -17	-94%	-$11K	﹤0.01%	3159
2021 Q1	$14K	Buy	18 +5	+38%	+$5.03K	﹤0.01%	2001
2020 Q4	$14K	Buy	+13	New	+$9.03K	﹤0.01%	1932
2019 Q1	–	Sell	-2,367	Closed	-$1.08M	–	3020
2018 Q4	$1.08M	Buy	2,367 +1,632	+222%	+$960K	0.07%	333
2018 Q3	$507K	Hold	735	–	–	0.02%	653
2018 Q2	$239K	Buy	735 +400	+119%	+$173K	0.01%	975
2018 Q1	$291K	Hold	335	–	–	0.01%	835
2017 Q4	$291K	Sell	335 -598	-64%	-$577K	0.01%	836
2017 Q3	$924K	Hold	933	–	–	0.04%	464
2017 Q2	$1.18M	Buy	+933	New	+$1.88M	0.05%	384

Other funds holding MTNB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return

Holos Integrated Wealth Kennett Square, Pennsylvania $223M AUM 9.55% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

IFP Advisors's MTNB Position: Q1 2025 in Review

IFP Advisors held its Matinas BioPharma (MTNB) position steady in Q1 2025 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #4527.

IFP Advisors first reported a position in MTNB in Q2 2017 and has held it in 22 quarters since. The position peaked at $1.18M in Q2 2017. 22 funds tracked by Wall St. Rank hold MTNB as of Q1 2025.

IFP Advisors held 0 shares of Matinas BioPharma worth $0 as of Q1 2025.
IFP Advisors left its Matinas BioPharma share count unchanged in Q1 2025.
Matinas BioPharma made up ﹤0.01% of IFP Advisors's portfolio in Q1 2025, its #4527 holding.
IFP Advisors first reported a position in Matinas BioPharma in Q2 2017 and has held it in 22 quarters since.
IFP Advisors's Matinas BioPharma position peaked at $1.18M in Q2 2017.
22 funds tracked by Wall St. Rank held Matinas BioPharma as of Q1 2025.

Based on IFP Advisors's 13F filing for Q1 2025, filed 5 May 2025.